J. Jaime Caro
Caro Research Institute
336 Baker Avenue
Concord
MA 01742
USA
Name/email consistency: high
- Cost-benefit analysis of preventing sudden cardiac deaths with an implantable cardioverter defibrillator versus amiodarone. Caro, J.J., Ward, A., Deniz, H.B., O'Brien, J.A., Ehreth, J.L. Value. Health (2007)
- Invasive meningococcal disease epidemiology and control measures: a framework for evaluation. Caro, J.J., Möller, J., Getsios, D., Coudeville, L., El-Hadi, W., Chevat, C., Nguyen, V.H., Caro, I. BMC. Public. Health (2007)
- Modelling the health benefits and economic implications of implanting dual-chamber vs. single-chamber ventricular pacemakers in the UK. Caro, J., Ward, A., Moller, J. Europace (2006)
- The time course of subsequent hospitalizations and associated costs in survivors of an ischemic stroke in Canada. Caro, J.J., Migliaccio-Walle, K., Ishak, K.J., Proskorovsky, I., O'Brien, J.A. BMC. Health. Serv. Res (2006)
- Pharmacoeconomic analyses using discrete event simulation. Caro, J.J. Pharmacoeconomics (2005)
- Economic burden of pertussis and the impact of immunization. Caro, J.J., Getsios, D., Payne, K., Annemans, L., Neumann, P.J., Trindade, E. Pediatr. Infect. Dis. J. (2005)
- Pertussis immunization of adolescents in the United States: an economic evaluation. Caro, J.J., Getsios, D., El-Hadi, W., Payne, K., O'Brien, J.A. Pediatr. Infect. Dis. J. (2005)
- The morbidity and mortality following a diagnosis of peripheral arterial disease: long-term follow-up of a large database. Caro, J., Migliaccio-Walle, K., Ishak, K.J., Proskorovsky, I. BMC. Cardiovasc. Disord (2005)
- Modeling the efficiency of reaching a target intermediate end point: a case study in type 2 diabetes in the United States. Caro, J.J., Salas, M., O'Brien, J.A., Ishak, K., Sung, J., Raggio, G. Value. Health (2004)
- The impact of compliance with osteoporosis therapy on fracture rates in actual practice. Caro, J.J., Ishak, K.J., Huybrechts, K.F., Raggio, G., Naujoks, C. Osteoporos. Int (2004)
- Comparing medications in a therapeutic area using an NNT model. Caro, J.J., Ishak, K.J., Caro, I., Migliaccio-Walle, K., Klittich, W.S. Value. Health (2004)
- Estimating survival for cost-effectiveness analyses: a case study in atherothrombosis. Caro, J.J., Ishak, K.J., Migliaccio-Walle, K. Value. Health (2004)
- Economic evaluation of therapeutic interventions to prevent Type 2 diabetes in Canada. Caro, J.J., Getsios, D., Caro, I., Klittich, W.S., O'Brien, J.A. Diabet. Med. (2004)
- Allocating funds for cardiovascular disease prevention in light of the NCEP ATP III guidelines. Caro, J., Huybrechts, K.F., Klittich, W.S., Jackson, J.D., McGuire, A. Am. J. Manag. Care (2003)
- Rational choice of cholinesterase inhibitor for the treatment of Alzheimer's disease in Canada: a comparative economic analysis. Caro, J., Getsios, D., Migliaccio-Walle, K., Ishak, J., El-Hadi, W. BMC. Geriatr (2003)
- Pharmacoeconomic evidence and considerations for triptan treatment of migraine. Caro, J.J., Getsios, D. Expert. Opin. Pharmacother (2002)
- Lifetime costs of complications resulting from type 2 diabetes in the U.S. Caro, J.J., Ward, A.J., O'Brien, J.A. Diabetes. Care (2002)
- Cost effectiveness of tinzaparin sodium versus unfractionated heparin in the treatment of proximal deep vein thrombosis. Caro, J.J., Getsios, D., Caro, I., O'Brien, J.A. Pharmacoeconomics (2002)
- Economic analysis of galantamine, a cholinesterase inhibitor, in the treatment of patients with mild to moderate Alzheimer's disease in the Netherlands. Caro, J.J., Salas, M., Ward, A., Getsios, D., Mehnert, A. Dement. Geriatr. Cogn. Disord (2002)
- To what degree does cognitive impairment in Alzheimer's disease predict dependence of patients on caregivers?. Caro, J., Ward, A., Ishak, K., Migliaccio-Walle, K., Getsios, D., Papadopoulos, G., Torfs, K. BMC. Neurol (2002)
- Estimates of the effect on hepatic iron of oral deferiprone compared with subcutaneous desferrioxamine for treatment of iron overload in thalassemia major: a systematic review. Caro, J., Huybrechts, K.F., Green, T.C. BMC. Blood. Disord (2002)
- The risk of diabetes during olanzapine use compared with risperidone use: a retrospective database analysis. Caro, J.J., Ward, A., Levinton, C., Robinson, K. J. Clin. Psychiatry (2002)
- Predicting treatment costs after acute ischemic stroke on the basis of patient characteristics at presentation and early dysfunction. Caro, J.J., Huybrechts, K.F., Kelley, H.E. Stroke (2001)
- Economic analysis of initial HIV treatment. Efavirenz- versus indinavir-containing triple therapy. Caro, J.J., O'Brien, J.A., Migliaccio-Walle, K., Raggio, G. Pharmacoeconomics (2001)
- Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Caro, J.J., Salas, M., Ward, A., Goss, G. Cancer (2001)
- Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials. Caro, J.J., Salas, M., Ward, A. Clin. Ther (2001)
- Assessment of health economics in Alzheimer's disease (AHEAD) based on need for full-time care. Caro, J.J., Getsios, D., Migliaccio-Walle, K., Raggio, G., Ward, A. Neurology (2001)
- Does electronic implementation of questionnaires used in asthma alter responses compared to paper implementation?. Caro, J.J., Caro, I., Caro, J., Wouters, F., Juniper, E.F. Qual. Life. Res (2001)
- Secondary prevention fallacy: pitfalls in comparing with primary. Caro, J.J., Huybrechts, K.F., Klittich, W.S. Expert. Rev. Pharmacoecon. Outcomes. Res (2001)
- Management patterns and costs of acute ischemic stroke : an international study. For the Stroke Economic Analysis Group. Caro, J.J., Huybrechts, K.F., Duchesne, I. Stroke (2000)
- Are the WOSCOPS clinical and economic findings generalizable to other populations? A case study for Belgium. The WOSCOPS Economic Analysis Group. West of Scotland Coronary Prevention Study. Caro, J.J., Huybrechts, K.F., De Backer, G., De Bacquer, D., Closon, M.C. Acta. Cardiol (2000)
- Could chest X-ray screening for lung cancer be cost-effective?. Caro, J.J., Klittich, W.S., Strauss, G. Cancer (2000)
- Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice. Caro, J.J., Flegel, K.M., Orejuela, M.E., Kelley, H.E., Speckman, J.L., Migliaccio-Walle, K. CMAJ (1999)
- Stroke treatment economic model (STEM): predicting long-term costs from functional status. Caro, J.J., Huybrechts, K.F. Stroke (1999)
- Persistence with treatment for hypertension in actual practice. Caro, J.J., Salas, M., Speckman, J.L., Raggio, G., Jackson, J.D. CMAJ (1999)
- Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data. Caro, J.J., Speckman, J.L., Salas, M., Raggio, G., Jackson, J.D. CMAJ (1999)
- The West of Scotland coronary prevention study: economic benefit analysis of primary prevention with pravastatin. Caro, J., Klittich, W., McGuire, A., Ford, I., Norrie, J., Pettitt, D., McMurray, J., Shepherd, J. BMJ (1997)
